Overexpression of HGF attenuates the degeneration of Purkinje cells and Bergmann glia in a knockin mouse model of spinocerebellar ataxia type 7

Neuroscience Research

Volumn 73, Issue 2, 2012, Pages 115-121

  Noma, Satsuki ^a,b   Ohya Shimada, Wakana ^a   Kanai, Masaaki ^a   Ueda, Keiji ^b   Nakamura, Toshikazu ^c   Funakoshi, Hiroshi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

C Met; GLAST; GLT 1; Glutamate transporter; Hepatocyte growth factor; Polyglutamine disease; SCA

Indexed keywords

GLUTAMATE TRANSPORTER; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BERGMANN GLIA LAYER; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIA; MALE; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PURKINJE CELL; SPINOCEREBELLAR ATAXIA TYPE 7; SPINOCEREBELLAR DEGENERATION; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; HEPATOCYTE GROWTH FACTOR; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE DEGENERATION; NEUROGLIA; PREGNANCY; PURKINJE CELLS; SPINOCEREBELLAR ATAXIAS;

EID: 84860342275     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2012.03.001     Document Type: Article

References (28)

1. Carter R.J., Morton J., Dunnett S.B. Motor coordination and balance in rodents. Curr. Protoc. Neurosci. 2001, (Chapter 8): Unit 8.12.
2. Custer S.K., Garden G.A., Gill N., Rueb U., Libby R.T., Schultz C., Guyenet S.J., Deller T., Westrum L.E., Sopher B.L., La Spada A.R. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat. Neurosci. 2006, 9:1302-1311.
3. Cvetanovic M., Patel J.M., Marti H.H., Kini A.R., Opal P. Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1. Nat. Med. 2011, 17:1445-1447.
4. Fryer J.D., Yu P., Kang H., Mandel-Brehm C., Carter A.N., Crespo-Barreto J., Gao Y., Flora A., Shaw C., Orr H.T., Zoghbi H.Y. Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua. Science 2011, 334:690-693.
5. Funakoshi H., Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin. Chim. Acta 2003, 327:1-23.
6. Funakoshi H., Nakamura T. Hepatocyte growth factor (HGF): neurotrophic functions and therapeutic implications for neuronal injury/diseases. Curr. Signal Transduct. Ther. 2011, 6:156-167.
7. Furrer S.A., Mohanachandran M.S., Waldherr S.M., Chang C., Damian V.A., Sopher B.L., Garden G.A., La Spada A.R. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous Bergmann glia degeneration. J. Neurosci. 2011, 31:16269-16278.
8. Huang H., Bordey A. Glial glutamate transporters limit spillover activation of presynaptic NMDA receptors and influence synaptic inhibition of Purkinje neurons. J. Neurosci. 2004, 24:5659-5669.
9. Honda S., Kagoshima M., Wanaka A., Tohyama M., Matsumoto K., Nakamura T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res. Mol. Brain Res. 1995, 32:197-210.
10. Hossain M.A., Russell J.C., Gomez R., Laterra J. Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB-independent. J. Neurochem. 2002, 81:365-378.
11. Ieraci A., Forni P.E., Ponzetto C. Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15200-15205.
12. Ishigaki A., Aoki M., Nagai M., Warita H., Kato S., Kato M., Nakamura T., Funakoshi H., Itoyama Y. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. J. Neuropathol. Exp. Neurol. 2007, 66:1037-1044.
13. Kadoyama K., Funakoshi H., Ohya W., Nakamura T. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci. Res. 2007, 59:446-456.
14. Kitamura K., Fujiyoshi K., Yamane J., Toyota F., Hikishima K., Nomura T., Funakoshi H., Nakamura T., Aoki M., Toyama Y., Okano H., Nakamura M. Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. PLoS One 2011, 6:e27706.
15. Machida S., Tanaka M., Ishii T., Ohtaka K., Takahashi T., Tazawa Y. Neuroprotective effect of hepatocyte growth factor against photoreceptor degeneration in rats. Invest. Ophthalmol. Vis. Sci. 2004, 45:4174-4182.
16. Miyazawa T., Matsumoto K., Ohmichi H., Katoh H., Yamashima T., Nakamura T. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J. Cereb. Blood Flow Metab. 1998, 18:345-348.
17. Mount H.T., Dean D.O., Alberch J., Dreyfus C.F., Black I.B. Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9092-9096.
18. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 1984, 122:1450-1459.
19. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443.
20. Ohtaka K., Machida S., Ohzeki T., Tanaka M., Kurosaka D., Masuda T., Ishii T. Protective effect of hepatocyte growth factor against degeneration of the retinal pigment epithelium and photoreceptor in sodium iodate-injected rats. Curr. Eye Res. 2006, 31:347-355.
21. Ohya W., Funakoshi H., Kurosawa T., Nakamura T. Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat. Brain Res. 2007, 1147:51-65.
22. Shibuki H., Katai N., Kuroiwa S., Kurokawa T., Arai J., Matsumoto K., Nakamura T., Yoshimura N. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 2002, 43:528-536.
23. Sun W., Funakoshi H., Nakamura T. Differential expression of hepatocyte growth factor and its receptor, c-Met in the rat retina during development. Brain Res. 1999, 851:46-53.
24. Sun W., Funakoshi H., Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J. Neurosci. 2002, 22:6537-6548.
25. Yamada A., Matsumoto K., Iwanari H., Sekiguchi K., Kawata S., Matsuzawa Y., Nakamura T. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed. Res. 1995, 16:105-114.
26. Yasuda S., Goto Y., Takaki H., Asaumi Y., Baba T., Miyazaki S., Nonogi H. Exercise-induced hepatocyte growth factor production in patients after acute myocardial infarction: its relationship to exercise capacity and brain natriuretic peptide levels. Circ. J. 2004, 68:304-307.
27. Yoo S.Y., Pennesi M.E., Weeber E.J., Xu B., Atkinson R., Chen S., Armstrong D.L., Wu S.M., Sweatt J.D., Zoghbi H.Y. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron 2003, 37:383-401.
28. Zhang L., Himi T., Morita I., Murota S. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway. J. Neurosci. Res. 2000, 59:489-496.